COMMUNIQUÉS West-GlobeNewswire

Apixio’s AI-Based Technology Delivers More Accurate Risk Adjustment to Meet Industry Demand for Compliant Solutions
19/12/2017
SAN MATEO, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Apixio Inc., the data science company for healthcare , is enabling healthcare organizations across the country to gather a more accurate picture of actively treated [...]
INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Refractory Childhood Absence Epilepsy in Pediatric Patients
19/12/2017
PHOENIX, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Can a synthetic formulation of cannabidiol (CBD), one of the main molecules in cannabis, safely help control treatment-resistant “staring” seizures in children with epilepsy? [...]
Delcath Announces Preliminary Safety Analysis for Phase 3 Focus Trial
19/12/2017
NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the independent Data [...]
Xbrane Biopharma signs agreement with BL&H for sales and marketing of Spherotide in South Korea
19/12/2017
Press release 2017-12-19 Xbrane Biopharma AB ("Xbrane" or "the Company") has signed a distribution agreement with BL&H for sales and marketing of Spherotide in South Korea. Xbrane will receive mid-single digit SEK [...]
Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific
19/12/2017
The test serves as a companion diagnostic for three targeted therapies in non-small cell lung cancer (NSCLC) Global NSCLC diagnostic market projected to reach $3.65 billion by 2024 RUTHERFORD, N.J., Dec. 19, 2017 (GLOBE [...]
BioCorRx Submits Pre-IND Package to FDA for its Naltrexone Implant, BICX102
19/12/2017
ANAHEIM, CA, Dec. 19, 2017 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that it has [...]
REPEAT – Cannabis Wheaton Income Corp. Announces Exclusive Data Licensing Agreement With Prominent Cannabis Testing, Analysis and Rating Company
19/12/2017
VANCOUVER, British Columbia, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (“ Wheaton Income ” or the “ Company ”) is pleased to announce that it has entered into an [...]
Onconova Therapeutics Announces License and Collaborative Development Agreement with HanX Biopharmaceuticals for ON 123300, a Dual Inhibitor of CDK4/6 + ARK5
19/12/2017
HanX to commercialize in Greater China: Onconova retains rights in rest of the world HanX will fund studies towards Investigational New Drug (IND) applications in both the US and China Agreement includes licensing fee, [...]
Myriad Genetics to Present at the 36th Annual J.P. Morgan Healthcare Conference
19/12/2017
SALT LAKE CITY, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
Faron Pharmaceuticals Oy: Study update: Traumakine® Phase II/III INFORAAA trial for Multi-Organ Failure receives recommendation from IDMC
19/12/2017
Faron Pharmaceuticals Ltd ("Faron" or the "Company") Study update: Traumakine ® Phase II/III INFORAAA trial for Multi-Organ Failure receives recommendation from IDMC First recommendation received from the IDMC to [...]
PTS Diagnostics Announces New Portable Data Capture System for Screening Professionals
19/12/2017
INDIANAPOLIS, Dec. 19, 2017 (GLOBE NEWSWIRE) -- PTS Diagnostics, a U.S.–based manufacturer of point-of-care biometric testing devices, today announced that they are releasing PTS Connect TM ScreenPro, a portable data [...]
REGENXBIO Announces IND Active for Phase I/II Trial of RGX-121 to Treat Mucopolysaccharidosis Type II
19/12/2017
Novel, one-time, direct-to-CNS treatment for MPS II focused toward potentially preventing the progression of cognitive deficits Clinical trial expected to enroll children with MPS II Anticipate beginning trial [...]
Asterias Biotherapeutics Completes Enrollment of Entire SCiStar Study
19/12/2017
FREMONT, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced enrollment and dosing of the last [...]
Axsome Therapeutics to Present at Biotech Showcase 2018
19/12/2017
NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Aclaris Therapeutics Initiates a Pilot Clinical Trial to Study ATI-50002 Topical in Patients with Vitiligo
19/12/2017
MALVERN, Pa., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and [...]
COPE Health Solutions expands COPE Health Scholars programs to Hawaii with Adventist Health Castle
19/12/2017
LOS ANGELES, Dec. 19, 2017 (GLOBE NEWSWIRE) -- COPE Health Solutions , a national health care advisory firm, is teaming up with Adventist Health Castle , a 160-bed hospital in Kailua, Hawaii, to launch its COPE Health [...]
ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares
19/12/2017
PORTLAND, Maine, Dec. 19, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (“ImmuCell” or the “Company”) (Nasdaq: ICCC ), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Amarin Announces REDUCE-IT Cardiovascular Outcomes Study Final Patient Visits to Commence in March 2018
19/12/2017
BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Amphastar Announces Approval for Sodium Nitroprusside Injection, USP
19/12/2017
RANCHO CUCAMONGA, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that today the U.S. Food and Drug Administration (“FDA”) granted approval of its abbreviated new drug [...]

Pages